Nuveen Asset Management, LLC Orgenesis Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.19 - $5.88 $375,193 - $526,524	-89,545 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.77 - $8.08 $26,440 - $44,787	-5,543 Reduced 5.83%	89,545 $513,000
Q4 2020 Feb 16, 2021	BUY	$4.4 - $5.63 $12,020 - $15,381	2,732 Added 2.96%	95,088 $428,000
Q3 2020 Nov 16, 2020	BUY	$4.75 - $5.99 $65,911 - $83,117	13,876 Added 17.68%	92,356 $465,000
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.84 $282,528 - $615,283	78,480 New	78,480 $477,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.